Cargando…

Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer

Among 124 older adults with advanced cancer who were hospitalized with pneumonia, 7.3% met criteria for postobstructive pneumonia. There were no differences in antibiotic duration, antibiotic spectrum, 30-day and 90-day readmissions, or mortality between those with and without postobstructive pneumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seohyuk, O’Donovan, Lisa, Cohen, Avi J., Gautam, Samir, Quagliarello, Vincent, Juthani-Mehta, Manisha, Datta, Rupak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726473/
https://www.ncbi.nlm.nih.gov/pubmed/36483405
http://dx.doi.org/10.1017/ash.2022.293
_version_ 1784844793730301952
author Lee, Seohyuk
O’Donovan, Lisa
Cohen, Avi J.
Gautam, Samir
Quagliarello, Vincent
Juthani-Mehta, Manisha
Datta, Rupak
author_facet Lee, Seohyuk
O’Donovan, Lisa
Cohen, Avi J.
Gautam, Samir
Quagliarello, Vincent
Juthani-Mehta, Manisha
Datta, Rupak
author_sort Lee, Seohyuk
collection PubMed
description Among 124 older adults with advanced cancer who were hospitalized with pneumonia, 7.3% met criteria for postobstructive pneumonia. There were no differences in antibiotic duration, antibiotic spectrum, 30-day and 90-day readmissions, or mortality between those with and without postobstructive pneumonia. Bacteria were identified in 5 patients with postobstructive pneumonia.
format Online
Article
Text
id pubmed-9726473
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-97264732022-12-07 Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer Lee, Seohyuk O’Donovan, Lisa Cohen, Avi J. Gautam, Samir Quagliarello, Vincent Juthani-Mehta, Manisha Datta, Rupak Antimicrob Steward Healthc Epidemiol Concise Communication Among 124 older adults with advanced cancer who were hospitalized with pneumonia, 7.3% met criteria for postobstructive pneumonia. There were no differences in antibiotic duration, antibiotic spectrum, 30-day and 90-day readmissions, or mortality between those with and without postobstructive pneumonia. Bacteria were identified in 5 patients with postobstructive pneumonia. Cambridge University Press 2022-09-08 /pmc/articles/PMC9726473/ /pubmed/36483405 http://dx.doi.org/10.1017/ash.2022.293 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Concise Communication
Lee, Seohyuk
O’Donovan, Lisa
Cohen, Avi J.
Gautam, Samir
Quagliarello, Vincent
Juthani-Mehta, Manisha
Datta, Rupak
Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
title Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
title_full Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
title_fullStr Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
title_full_unstemmed Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
title_short Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
title_sort prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726473/
https://www.ncbi.nlm.nih.gov/pubmed/36483405
http://dx.doi.org/10.1017/ash.2022.293
work_keys_str_mv AT leeseohyuk prevalenceandtreatmentofpostobstructivepneumoniaamongolderadultswithadvancedcancer
AT odonovanlisa prevalenceandtreatmentofpostobstructivepneumoniaamongolderadultswithadvancedcancer
AT cohenavij prevalenceandtreatmentofpostobstructivepneumoniaamongolderadultswithadvancedcancer
AT gautamsamir prevalenceandtreatmentofpostobstructivepneumoniaamongolderadultswithadvancedcancer
AT quagliarellovincent prevalenceandtreatmentofpostobstructivepneumoniaamongolderadultswithadvancedcancer
AT juthanimehtamanisha prevalenceandtreatmentofpostobstructivepneumoniaamongolderadultswithadvancedcancer
AT dattarupak prevalenceandtreatmentofpostobstructivepneumoniaamongolderadultswithadvancedcancer